Transcriptomic and proteomic analyses reveal key innate immune signatures in the host response to the gastrointestinal pathogen Campylobacter concisus

Infection and Immunity

Volumn 83, Issue 2, 2015, Pages 832-845

  Kaakoush, Nadeem O ^a   Deshpande, Nandan P ^a   Man, Si Ming ^b   Burgos Portugal, Jose A ^a   Khattak, Faisal A ^a   Raftery, Mark J ^a   Wilkins, Marc R ^a   Mitchell, Hazel M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR; MICRORNA; PATTERN RECOGNITION RECEPTOR; RNA; STAT PROTEIN; UNTRANSLATED RNA; CREB1 PROTEIN, HUMAN; IFI16 PROTEIN, HUMAN; LONG UNTRANSLATED RNA; MIRN221 MICRORNA, HUMAN; NUCLEAR PROTEIN; PHOSPHOPROTEIN;

ARTICLE; BACTERIAL STRAIN; CAMPYLOBACTER CONCISUS; CAMPYLOBACTERIOSIS; CARCINOGENESIS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INNATE IMMUNITY; MACROPHAGE; MASS SPECTROMETRY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RNA SEQUENCE; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS; UPREGULATION; BIOSYNTHESIS; CAMPYLOBACTER; GASTROINTESTINAL DISEASE; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; MICROBIOLOGY; NUCLEOTIDE SEQUENCE; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; TUMOR CELL LINE;

BASE SEQUENCE; CAMPYLOBACTER; CAMPYLOBACTER INFECTIONS; CELL LINE, TUMOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; GASTROINTESTINAL DISEASES; GENE EXPRESSION PROFILING; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTERFERON REGULATORY FACTORS; MACROPHAGES; MASS SPECTROMETRY; MICRORNAS; MICROSCOPY, CONFOCAL; NF-KAPPA B; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROTEIN INTERACTION MAPS; PROTEOMICS; RECEPTORS, PATTERN RECOGNITION; RNA, LONG NONCODING; SEQUENCE ANALYSIS, RNA; STAT TRANSCRIPTION FACTORS;

EID: 84921415239     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.03012-14     Document Type: Article

References (76)

1. Man SM. 2011. The clinical importance of emerging Campylobacter species. Nat Rev Gastroenterol Hepatol 8:669-685. http://dx.doi.org/10.1038/nrgastro.2011.191.
2. Tanner AC, Badger S, Lai C-H, Listgarten MA, Visconti RA, Socransky SS. 1981. Wolinella gen. nov., Wolinella succinogenes (Vibrio succinogenes Wolin et al.) comb. nov., and description of Bacteroides gracilis sp. nov., Wolinella recta sp. nov., Campylobacter concisus sp. nov., and Eikenella corrodens from humans with periodontal disease. Int J Syst Bacteriol 31: 432-445. http://dx.doi.org/10.1099/00207713-31-4-432.
3. Kaakoush NO, Mitchell HM. 2012. Campylobacter concisus-a new player in intestinal disease. Front Cell Infect Microbiol 2:4. http://dx.doi.org/10.3389/fcimb.2012.00004.
4. Lastovica AJ. 2009. Clinical relevance of Campylobacter concisus isolated from pediatric patients. J Clin Microbiol 47:2360-2360. http://dx.doi.org/10.1128/JCM.00568-09.
5. Nielsen H, Ejlertsen T, Engberg J, Nielsen H. 2013. High incidence of Campylobacter concisus in gastroenteritis in North Jutland, Denmark: a population-based study. Clin Microbiol Infect 19:445-450. http://dx.doi.org/10.1111/j.1469-0691.2012.03852.x.
6. Nielsen H, Engberg J, Ejlertsen T, Bücker R, Nielsen H. 2012. Shortterm and medium-term clinical outcomes of Campylobacter concisus infection. Clin Microbiol Infect 18:E459-E465. http://dx.doi.org/10.1111/j.1469-0691.2012.03990.x.
7. Nielsen HL, Engberg J, Ejlertsen T, Nielsen H. 2014. Psychometric scores and persistence of irritable bowel after Campylobacter concisus infection. Scand J Gastroenterol 49:545-551. http://dx.doi.org/10.3109/00365521.2014.886718.
8. Kaakoush NO, Castaño-Rodríguez N, Day AS, Lemberg DA, Leach ST, Mitchell HM. 2014. Campylobacter concisus and exotoxin 9 levels in paediatric patients with Crohn's disease and their association with the intestinal microbiota. J Med Microbiol 63:99-105. http://dx.doi.org/10.1099/jmm.0.067231-0.
9. Kovach Z, Kaakoush NO, Lamb S, Zhang L, Raftery MJ, Mitchell H. 2011. Immunoreactive proteins of Campylobacter concisus, an emergent intestinal pathogen. FEMS Immunol Med Microbiol 63:387-396. http://dx.doi.org/10.1111/j.1574-695X.2011.00864.x.
10. Mahendran V, Riordan SM, Grimm MC, Tran TA, Major J, Kaakoush NO, Mitchell H, Zhang L. 2011. Prevalence of Campylobacter species in adult Crohn's disease and the preferential colonization sites of Campylobacter species in the human intestine. PLoS One 6:e25417. http://dx.doi.org/10.1371/journal.pone.0025417.
11. Man SM, Zhang L, Day AS, Leach ST, Lemberg DA, Mitchell H. 2010. Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohn's disease. Inflamm Bowel Dis 16:1008-1016. http://dx.doi.org/10.1002/ibd.21157.
12. Mukhopadhya I, Thomson JM, Hansen R, Berry SH, El-Omar EM, Hold GL. 2011. Detection of Campylobacter concisus and other Campylobacter species in colonic biopsies from adults with ulcerative colitis. PLoS One 6:e21490. http://dx.doi.org/10.1371/journal.pone.0021490.
13. Zhang L, Man SM, Day AS, Leach ST, Lemberg DA, Dutt S, Stormon M, Otley A, O'Loughlin EV, Magoffin A, Ng PH, Mitchell H. 2009. Detection and isolation of Campylobacter species other than C. jejuni from children with Crohn's disease. J Clin Microbiol 47:453-455. http://dx.doi.org/10.1128/JCM.01949-08.
14. Blackett K, Siddhi S, Cleary S, Steed H, Miller M, Macfarlane S, Macfarlane G, Dillon J. 2013. Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality? Aliment Pharmacol Ther 37:1084-1092. http://dx.doi.org/10.1111/apt.12317.
15. Macfarlane S, Furrie E, Macfarlane GT, Dillon JF. 2007. Microbial colonization of the upper gastrointestinal tract in patients with Barrett's esophagus. Clin Infect Dis 45:29-38. http://dx.doi.org/10.1086/518578.
16. Kaakoush NO, Mitchell HM, Man SM. 2014. Role of emerging Campylobacter species in inflammatory bowel diseases. Inflamm Bowel Dis 20: 2189-2197. http://dx.doi.org/10.1097/MIB.0000000000000074.
17. Burgos-Portugal JA, Mitchell HM, Castano-Rodriguez N, Kaakoush NO. 2014. The role of autophagy in the intracellular survival of Campylobacter concisus. FEBS Open Bio 4:301-309. http://dx.doi.org/10.1016/j.fob.2014.03.008.
18. Kaakoush NO, Deshpande NP, Wilkins MR, Tan CG, Burgos-Portugal JA, Raftery MJ, Day AS, Lemberg DA, Mitchell H. 2011. The pathogenic potential of Campylobacter concisus strains associated with chronic intestinal diseases. PLoS One 6:e29045. http://dx.doi.org/10.1371/journal.pone.0029045.
19. Man SM, Kaakoush NO, Leach ST, Nahidi L, Lu HK, Norman J, Day AS, Zhang L, Mitchell HM. 2010. Host attachment, invasion, and stimulation of proinflammatory cytokines by Campylobacter concisus and other non-Campylobacter jejuni Campylobacter species. J Infect Dis 202: 1855-1865. http://dx.doi.org/10.1086/657316.
20. Kaakoush NO, Man SM, Lamb S, Raftery MJ, Wilkins MR, Kovach Z, Mitchell H. 2010. The secretome of Campylobacter concisus. FEBS J 277: 1606-1617. http://dx.doi.org/10.1111/j.1742-4658.2010.07587.x.
21. Deshpande NP, Kaakoush NO, Wilkins MR, Mitchell HM. 2013. Comparative genomics of Campylobacter concisus isolates reveals genetic diversity and provides insights into disease association.BMCGenomics 14:585. http://dx.doi.org/10.1186/1471-2164-14-585.
22. Edwards LA, Nistala K, Mills DC, Stephenson HN, Zilbauer M, Wren BW, Dorrell N, Lindley KJ, Wedderburn LR, Bajaj-Elliott M. 2010. Delineation of the innate and adaptive T-cell immune outcome in the human host in response to Campylobacter jejuni infection. PLoS One 5:e15398. http://dx.doi.org/10.1371/journal.pone.0015398.
23. Hu L, Bray MD, Geng Y, Kopecko DJ. 2012. Campylobacter jejunimediated induction of CC and CXC chemokines and chemokine receptors in human dendritic cells. Infect Immun 80:2929-2939. http://dx.doi.org/10.1128/IAI.00129-12.
24. Hu L, Bray MD, Osorio M, Kopecko DJ. 2006. Campylobacter jejuni induces maturation and cytokine production in human dendritic cells. Infect Immun 74:2697-2705. http://dx.doi.org/10.1128/IAI.74.5.2697-2705.2006.
25. Rathinam VA, Appledorn DM, Hoag KA, Amalfitano A, Mansfield LS. 2009. Campylobacter jejuni-induced activation of dendritic cells involves cooperative signaling through Toll-like receptor 4 (TLR4)-MyD88 and TLR4-TRIF axes. Infect Immun 77:2499-2507. http://dx.doi.org/10.1128/IAI.01562-08.
26. Zilbauer M, Dorrell N, Elmi A, Lindley KJ, Schüller S, Jones HE, Klein NJ, Núňez G, Wren BW, Bajaj-Elliott M. 2007. A major role for intestinal epithelial nucleotide oligomerization domain 1 (NOD1) in eliciting host bactericidal immune responses to Campylobacter jejuni. Cell Microbiol 9:2404-2416. http://dx.doi.org/10.1111/j.1462-5822.2007.00969.x.
27. Anders S, Huber W. 2010. Differential expression analysis for sequence count data. Genome Biol 11:R106. http://dx.doi.org/10.1186/gb-2010-11-10-r106.
28. Robinson MD, McCarthy DJ, Smyth GK. 2010. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26:139-140. http://dx.doi.org/10.1093/bioinformatics/btp616.
29. Fernandes-Alnemri T, Alnemri ES. 2008. Chapter thirteen assembly, purification, and assay of the activity of the ASC pyroptosome. Methods Enzymol 442:251-270. http://dx.doi.org/10.1016/S0076-6879(08)01413-4.
30. Hart-Smith G, Raftery MJ. 2012. Detection and characterization of low abundance glycopeptides via higher-energy C-trap dissociation and Orbitrap mass analysis. J Am Soc Mass Spectrom 23:124-140. http://dx.doi.org/10.1007/s13361-011-0273-y.
31. Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, Workman C, Christmas R, Avila-Campilo I, Creech M, Gross B. 2007. Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2:2366-2382. http://dx.doi.org/10.1038/nprot.2007.324.
32. van Sorge NM, Bleumink N, Van Vliet SJ, Saeland E, Van Der Pol W, Van Kooyk Y, Van Putten JP. 2009. N-glycosylated proteins and distinct lipooligosaccharide glycoforms of Campylobacter jejuni target the human C-type lectin receptor MGL. Cell Microbiol 11:1768-1781. http://dx.doi.org/10.1111/j.1462-5822.2009.01370.x.
33. Nothaft H, Scott NE, Vinogradov E, Liu X, Hu R, Beadle B, Fodor C, Miller WG, Li J, Cordwell SJ. 2012. Diversity in the protein N-glycosylation pathways within the Campylobacter genus. Mol Cell Proteomics 11:1203-1219. http://dx.doi.org/10.1074/mcp.M112.021519.
34. Deretic V. 2012. Autophagy as an innate immunity paradigm: expanding the scope and repertoire of pattern recognition receptors. Curr Opin Immunol 24:21-31. http://dx.doi.org/10.1016/j.coi.2011.10.006.
35. Bouwman LI, de Zoete MR, Bleumink-Pluym NM, Flavell RA, van Putten JP. 2014. Inflammasome activation by Campylobacter jejuni. J Immunol 193:4548-4557. http://dx.doi.org/10.4049/jimmunol.1400648.
36. Benko S, Magalhaes JG, Philpott DJ, Girardin SE. 2010. NLRC5 limits the activation of inflammatory pathways. J Immunol 185:1681-1691. http://dx.doi.org/10.4049/jimmunol.0903900.
37. Cui J, Zhu L, Xia X, Wang HY, Legras X, Hong J, Ji J, Shen P, Zheng S, Chen ZJ. 2010. NLRC5 negatively regulates the NF-κB and type I interferon signaling pathways. Cell 141:483-496. http://dx.doi.org/10.1016/j.cell.2010.03.040.
38. Meissner TB, Li A, Biswas A, Lee K-H, Liu Y-J, Bayir E, Iliopoulos D, van den Elsen PJ, Kobayashi KS. 2010. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proc Natl Acad Sci U S A 107:13794-13799. http://dx.doi.org/10.1073/pnas.1008684107.
39. Allen IC, Wilson JE, Schneider M, Lich JD, Roberts RA, Arthur JC, Woodford R-MT, Davis BK, Uronis JM, Herfarth HH. 2012. NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling. Immunity 36:742-754. http://dx.doi.org/10.1016/j.immuni.2012.03.012.
40. Lich JD, Williams KL, Moore CB, Arthur JC, Davis BK, Taxman DJ, Ting JP. 2007. Cutting edge: Monarch-1 suppresses non-canonical NF-κB activation and p52-dependent chemokine expression in monocytes. J Immunol 178:1256-1260. http://dx.doi.org/10.4049/jimmunol.178.3.1256.
41. Xia X, Cui J, Wang HY, Zhu L, Matsueda S, Wang Q, Yang X, Hong J, Songyang Z, Chen ZJ. 2011. NLRX1 negatively regulates TLR-induced NF-κB signaling by targeting TRAF6 and IKK. Immunity 34:843-853. http://dx.doi.org/10.1016/j.immuni.2011.02.022.
42. Zaki MH, Vogel P, Malireddi R, Body-Malapel M, Anand PK, Bertin J, Green DR, Lamkanfi M, Kanneganti T-D. 2011. The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. Cancer Cell 20:649-660. http://dx.doi.org/10.1016/j.ccr.2011.10.022.
43. Siegesmund AM, Konkel ME, Klena JD, Mixter PF. 2004. Campylobacter jejuni infection of differentiated THP-1 macrophages results in interleu-kin 1β release and caspase-1-independent apoptosis. Microbiology 150: 561-569. http://dx.doi.org/10.1099/mic.0.26466-0.
44. Shi J, Zhao Y, Wang Y, Gao W, Ding J, Li P, Hu L, Shao F. 2014. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature http://dx.doi.org/10.1038/nature13683.
45. Lamkanfi M, Kanneganti T-D. 2010. Nlrp3: an immune sensor of cellular stress and infection. Int J Biochem Cell Biol 42:792-795. http://dx.doi.org/10.1016/j.biocel.2010.01.008.
46. Lamkanfi M, Kanneganti T-D, Van Damme P, Berghe TV, Vanoverberghe I, Vandekerckhove J, Vandenabeele P, Gevaert K, Núñez G. 2008. Targeted peptidecentric proteomics reveals caspase-7 as a substrate of the caspase-1 inflammasomes. Mol Cell Proteomics 7:2350-2363. http://dx.doi.org/10.1074/mcp.M800132-MCP200.
47. Erener S, Pétrilli V, Kassner I, Minotti R, Castillo R, Santoro R, Hassa PO, Tschopp J, Hottiger MO. 2012. Inflammasome-activated caspase 7 cleaves PARP1 to enhance the expression of a subset of NF-κB target genes. Mol Cell 46:200-211. http://dx.doi.org/10.1016/j.molcel.2012.02.016.
48. Cassidy SK, Hagar JA, Kanneganti TD, Franchi L, Nuñez G, O'Riordan MX. 2012. Membrane damage during Listeria monocytogenes infection triggers a caspase-7 dependent cytoprotective response. PLoS Pathog 8:e1002628. http://dx.doi.org/10.1371/journal.ppat.1002628.
49. Fujimoto M, Naka T. 2003. Regulation of cytokine signaling by SOCS family molecules. Trends Immunol 24:659-666. http://dx.doi.org/10.1016/j.it.2003.10.008.
50. Fujimoto M, Naka T. 2010. SOCS1, a negative regulator of cytokine signals and TLR responses, in human liver diseases. Gastroenterol Res Pract 2010:470468. http://dx.doi.org/10.1155/2010/470468.
51. Frey H, Schroeder N, Manon-Jensen T, Iozzo RV, Schaefer L. 2013. Biological interplay between proteoglycans and their innate immune receptors in inflammation. FEBS J 280:2165-2179. http://dx.doi.org/10.1111/febs.12145.
52. Kerur N, Veettil MV, Sharma-Walia N, Bottero V, Sadagopan S, Otageri P, Chandran B. 2011. IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi sarcoma-associated herpesvirus infection. Cell Host Microbe 9:363-375. http://dx.doi.org/10.1016/j.chom.2011.04.008.
53. Richards CD. 2013. The enigmatic cytokine oncostatin M and roles in disease. ISRN Inflamm 2013:512103. http://dx.doi.org/10.1155/2013/512103.
54. Mayr B, Montminy M. 2001. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2:599-609. http://dx.doi.org/10.1038/35085068.
55. Wen AY, Sakamoto KM, Miller LS. 2010. The role of the transcription factor CREB in immune function. J Immunol 185:6413-6419. http://dx.doi.org/10.4049/jimmunol.1001829.
56. Hsu L-C, Park JM, Zhang K, Luo J-L, Maeda S, Kaufman RJ, Eckmann L, Guiney DG, Karin M. 2004. The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 428: 341-345. http://dx.doi.org/10.1038/nature02405.
57. Park JM, Greten FR, Wong A, Westrick RJ, Arthur JSC, Otsu K, Hoffmann A, Montminy M, Karin M. 2005. Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis-CREB and NF-κB as key regulators. Immunity 23:319-329. http://dx.doi.org/10.1016/j.immuni.2005.08.010.
58. Ananieva O, Darragh J, Johansen C, Carr JM, McIlrath J, Park JM, Wingate A, Monk CE, Toth R, Santos SG. 2008. The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling. Nat Immunol 9:1028-1036. http://dx.doi.org/10.1038/ni.1644.
59. Kasinski A, Dong X, Khuri FR, Boss J, Fu H. 2014. Transcriptional regulation of YWHAZ, the gene encoding 14-3-3ζ. PLoS One 9:e93480. http://dx.doi.org/10.1371/journal.pone.0093480.
60. Ulvila J, Vanha-aho L-M, Kleino A, Vähä-Mäkilä M, Vuoksio M, Eskelinen S, Hultmark D, Kocks C, Hallman M, Parikka M. 2011. Cofilin regulator 14-3-3ζ is an evolutionarily conserved protein required for phagocytosis and microbial resistance. J Leukoc Biol 89:649-659. http://dx.doi.org/10.1189/jlb.0410195.
61. Song X, Cao G, Jing L, Lin S, Wang X, Zhang J, Wang M, Liu W, Lv C. 2014. Analysing the relationship between lncRNA and protein-coding gene and the role of lncRNA as ceRNA in pulmonary fibrosis. J Cell Mol Med 18:991-1003. http://dx.doi.org/10.1111/jcmm.12243.
62. Kono T, Bird S, Sonoda K, Savan R, Secombes CJ, Sakai M. 2008. Characterization and expression analysis of an interleukin-7 homologue in the Japanese pufferfish, Takifugu rubripes. FEBS J 275:1213-1226. http://dx.doi.org/10.1111/j.1742-4658.2008.06281.x.
63. Handel AE, Handunnetthi L, Berlanga AJ, Watson CT, Morahan JM, Ramagopalan SV. 2010. The effect of single nucleotide polymorphisms from genome wide association studies in multiple sclerosis on gene expression. PLoS One 5:e10142. http://dx.doi.org/10.1371/journal.pone.0010142.
64. Dooms H. 2013. Interleukin-7: fuel for the autoimmune attack. J Autoimmun 45:40-48. http://dx.doi.org/10.1016/j.jaut.2013.06.007.
65. Hsu H-C, Mountz JD. 2010. Metabolic syndrome, hormones, and maintenance of T cells during aging. Curr Opin Immunol 22:541-548. http://dx.doi.org/10.1016/j.coi.2010.05.002.
66. Kumar A, Takada Y, Boriek AM, Aggarwal BB. 2004. Nuclear factor-κB: its role in health and disease. J Mol Med 82:434-448. http://dx.doi.org/10.1007/s00109-004-0555-y.
67. Takao K, Kobayashi K, Hagihara H, Ohira K, Shoji H, Hattori S, Koshimizu H, Umemori J, Toyama K, Nakamura HK. 2013. Deficiency of Schnurri-2, an MHC enhancer binding protein, induces mild chronic inflammation in the brain and confers molecular, neuronal, and behavioral phenotypes related to schizophrenia. Neuropsychopharmacology 38:1409-1425. http://dx.doi.org/10.1038/npp.2013.38.
68. Song HY, Rothe M, Goeddel DV. 1996. The tumor necrosis factorinducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. Proc Natl Acad Sci U S A 93:6721-6725. http://dx.doi.org/10.1073/pnas.93.13.6721.
69. Wullaert A, Verstrepen L, Van Huffel S, Adib-Conquy M, Cornelis S, Kreike M, Haegman M, El Bakkouri K, Sanders M, Verhelst K. 2007. LIND/ABIN-3 is a novel lipopolysaccharide-inducible inhibitor of NF-κB activation. J Biol Chem 282:81-90. http://dx.doi.org/10.1074/jbc.M607481200.
70. Fu Q, Shi H, Shi M, Meng L, Zhang H, Ren Y, Guo F, Jia B, Wang P, Ni W. 2014. Bta-miR-29b attenuates apoptosis via directly targeting caspase-7 and NAIF1 and suppresses bovine virus diarrhea virus replication in MDBK cells. Can J Microbiol 60:455-460. http://dx.doi.org/10.1139/cjm-2014-0277.
71. Zeng Z, Gong H, Li Y, Jie K, Ding C, Shao Q, Liu F, Zhan Y, Nie C, Zhu W. 2013. Upregulation of miR-146a contributes to the suppression of inflammatory responses in LPS-induced acute lung injury. Exp Lung Res 39:275-282. http://dx.doi.org/10.3109/01902148.2013.808285.
72. Hou ZH, Han QJ, Zhang C, Tian ZG, Zhang J. 2014. miR146a impairs the IFN-induced anti-HBV immune response by downregulating STAT1 in hepatocytes. Liver Int 34:58-68. http://dx.doi.org/10.1111/liv.12244.
73. Omrane I, Kourda N, Stambouli N, Privat M, Medimegh I, Arfaoui A, Uhrhammer N, Bougatef K, Baroudi O, Bouzaienne H. 2014. MicroRNAs 146a and 147b biomarkers for colorectal tumor's localization. BioMed Res Int 2014:584852. http://dx.doi.org/10.1155/2014/584852.
74. Liu S, Sun X, Wang M, Hou Y, Zhan Y, Jiang Y, Liu Z, Cao X, Chen P, Liu Z. 2014. A microRNA 221-and 222-mediated feedback loop, via PDLIM2, maintains constitutive activation of NFκB and STAT3 in colorectal cancer cells. Gastroenterology 147:847-859. http://dx.doi.org/10.1053/j.gastro.2014.06.006.
75. Qin J, Luo M. 2014. MicroRNA-221 promotes colorectal cancer cell invasion and metastasis by targeting RECK. FEBS Lett 588:99-104. http://dx.doi.org/10.1016/j.febslet.2013.11.014.
76. Urbich C, Kuehbacher A, Dimmeler S. 2008. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 79: 581-588. http://dx.doi.org/10.1093/cvr/cvn156.